Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration

Aim: To describe the appearance of the non-exudative forms of age related macular degeneration (AMD) as imaged by ultrahigh resolution optical coherence tomography (UHR-OCT). Methods: A UHR-OCT ophthalmic imaging system, which utilises a femtosecond laser light source capable of ∼3 μm axial resolution, was employed to obtain retinal cross sectional images of patients with non-exudative AMD. Observational studies of the resulting retinal images were performed. Results: 52 eyes of 42 patients with the clinical diagnosis of non-exudative AMD were imaged using the UHR-OCT system. 47 of the 52 (90%) eyes had the clinical diagnosis of drusen and/or retinal pigment epithelial (RPE) changes. In these patients, three patterns of drusen were apparent on UHR-OCT: (1) distinct RPE excrescences, (2) a saw toothed pattern of the RPE, and (3) nodular drusen. On UHR-OCT, three eyes (6%) with a clinical diagnosis of non-exudative AMD had evidence of fluid under the retina or RPE. Two of these three patients had findings suspicious for subclinical choroidal neovascularisation on UHR-OCT. Conclusion: With the increased resolution of UHR-OCT compared to standard OCT, the involvement of the outer retinal layers are more clearly defined. UHR-OCT may allow for the detection of early exudative changes not visible clinically or by angiography.

[1]  M. Trese,et al.  Transretinal Pigment Migration: An Optical Coherence Tomographic Study , 2004 .

[2]  Angelika Unterhuber,et al.  Ultrahigh resolution optical coherence tomography of the monkey fovea. Identification of retinal sublayers by correlation with semithin histology sections. , 2004, Experimental eye research.

[3]  B. Hawkins,et al.  Krypton Laser photocoagulation for neovascular lesions of age-related macular degeneration. , 1991, Archives of ophthalmology.

[4]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[5]  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. , 2001 .

[6]  J. Fujimoto,et al.  In vivo retinal imaging by optical coherence tomography. , 1993, Optics letters.

[7]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[8]  Irene Barbazetto,et al.  Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. , 2003, Archives of ophthalmology.

[9]  A. Ho Effect of Lesion Size, Visual Acuity, and Lesion Composition on Visual Acuity Change With and Without Verteporfin Therapy for Choroidal Neovascularization Secondary To Age-Related Macular Degeneration: TAP and VIP Report No. 1 , 2004 .

[10]  Michael Stur,et al.  Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. , 2003, American journal of ophthalmology.

[11]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[12]  D. Zacks,et al.  Transretinal pigment migration: an optical coherence tomographic study. , 2004, Archives of ophthalmology.

[13]  E. Gragoudas,et al.  Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.

[14]  N. Bressler,et al.  Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6. , 2004, Archives of ophthalmology.

[15]  J. Duker,et al.  Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. , 1996, Ophthalmology.

[16]  J. Duker,et al.  Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular hole pathology and repair. , 2004, Ophthalmology.

[17]  W. Amoaku,et al.  Treatment of Age-Related Macular Degeneration , 2004, Journal of the Royal Society of Medicine.

[18]  Mauricio E Pons,et al.  Redefining the limit of the outer retina in optical coherence tomography scans. , 2005, Ophthalmology.

[19]  I Lavery,et al.  Safe use of lasers. , 1978, Occupational health; a journal for occupational health nurses.

[20]  G. Ripandelli,et al.  Optical coherence tomography. , 1998, Seminars in ophthalmology.

[21]  J. Fujimoto,et al.  Ultrahigh-resolution ophthalmic optical coherence tomography , 2001, Nature Medicine.

[22]  J. Fujimoto,et al.  Optical coherence tomography of the human retina. , 1995, Archives of ophthalmology.

[23]  W R Green,et al.  Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.

[24]  J. Fujimoto,et al.  Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. , 2003, Archives of ophthalmology.

[25]  A Hofman,et al.  Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. , 1998, Archives of ophthalmology.

[26]  J. Català Mora,et al.  Photodynamic Therapy Of Subfoveal Choroidal Neovascularization With Verteporfin. Fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP report nº2 , 2003 .

[27]  S. Sarks New vessel formation beneath the retinal pigment epithelium in senile eyes. , 1973, The British journal of ophthalmology.

[28]  M. Killingsworth,et al.  Evolution of soft drusen in age-related macular degeneration , 1994, Eye.

[29]  N. Bressler,et al.  Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.

[30]  M. Blumenkranz,et al.  Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. , 2002, Archives of ophthalmology.

[31]  N. Bressler,et al.  Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.